BACKGROUND: This study examined potential self-selection bias in a large pregnancy cohort by comparing exposure-outcome associations from the cohort to similar associations obtained from nationwide registry data. The outcome under study was specialist-confirmed diagnosis of autism spectrum disorders (ASDs). METHODS: The cohort sample (n = 89 836) was derived from the population-based prospective Norwegian Mother and Child Cohort Study and its substudy of ASDs, the Autism Birth Cohort (ABC) study. The nationwide registry data were derived from the Medical Birth Registry of Norway (n = 507 856). The children were born in 1999–2007, and seven prenatal and perinatal exposures were selected for analyses. RESULTS: ASDs were reported for 234 (0.26%) children in the cohort and 2072 (0.41%) in the nationwide population. Compared with the nationwide population, the cohort had an under-representation of the youngest women (<25 years), those who had single status, mothers who smoked during pregnancy, and non-users of prenatal folic acid supplements. The ratios of the adjusted odds ratios (ORs) in the cohort over the adjusted ORs in the nationwide population were as follows; primipara pregnancy: 1.39/1.22, prenatal folic acid use: 0.85/0.86, prenatal smoking: 1.20/1.17, preterm birth (<37 weeks): 1.48/1.42, low birthweight (<2500 g): 1.60/1.58, male sex: 4.39/4.59 (unadjusted only); and caesarean section history: 1.03/1.04. CONCLUSIONS: Associations estimated between ASDs and perinatal and prenatal exposures in the cohort are close to those estimated in the nationwide population. Self-selection does not appear to compromise validity of exposure-outcome associations in the ABC study.
BACKGROUND: This study examined potential self-selection bias in a large pregnancy cohort by comparing exposure-outcome associations from the cohort to similar associations obtained from nationwide registry data. The outcome under study was specialist-confirmed diagnosis of autism spectrum disorders (ASDs). METHODS: The cohort sample (n = 89 836) was derived from the population-based prospective Norwegian Mother and Child Cohort Study and its substudy of ASDs, the Autism Birth Cohort (ABC) study. The nationwide registry data were derived from the Medical Birth Registry of Norway (n = 507 856). The children were born in 1999–2007, and seven prenatal and perinatal exposures were selected for analyses. RESULTS: ASDs were reported for 234 (0.26%) children in the cohort and 2072 (0.41%) in the nationwide population. Compared with the nationwide population, the cohort had an under-representation of the youngest women (<25 years), those who had single status, mothers who smoked during pregnancy, and non-users of prenatal folic acid supplements. The ratios of the adjusted odds ratios (ORs) in the cohort over the adjusted ORs in the nationwide population were as follows; primipara pregnancy: 1.39/1.22, prenatal folic acid use: 0.85/0.86, prenatal smoking: 1.20/1.17, preterm birth (<37 weeks): 1.48/1.42, low birthweight (<2500 g): 1.60/1.58, male sex: 4.39/4.59 (unadjusted only); and caesarean section history: 1.03/1.04. CONCLUSIONS: Associations estimated between ASDs and perinatal and prenatal exposures in the cohort are close to those estimated in the nationwide population. Self-selection does not appear to compromise validity of exposure-outcome associations in the ABC study.
Authors: Costanza Pizzi; Bianca L De Stavola; Neil Pearce; Fulvio Lazzarato; Paola Ghiotti; Franco Merletti; Lorenzo Richiardi Journal: J Epidemiol Community Health Date: 2011-12-06 Impact factor: 3.710
Authors: Katja M Lampi; Liisa Lehtonen; Phuong Lien Tran; Auli Suominen; Venla Lehti; P Nina Banerjee; Mika Gissler; Alan S Brown; Andre Sourander Journal: J Pediatr Date: 2012-06-05 Impact factor: 4.406
Authors: Diana E Schendel; Carolyn Diguiseppi; Lisa A Croen; M Daniele Fallin; Philip L Reed; Laura A Schieve; Lisa D Wiggins; Julie Daniels; Judith Grether; Susan E Levy; Lisa Miller; Craig Newschaffer; Jennifer Pinto-Martin; Cordelia Robinson; Gayle C Windham; Aimee Alexander; Arthur S Aylsworth; Pilar Bernal; Joseph D Bonner; Lisa Blaskey; Chyrise Bradley; Jack Collins; Casara J Ferretti; Homayoon Farzadegan; Ellen Giarelli; Marques Harvey; Susan Hepburn; Matthew Herr; Kristina Kaparich; Rebecca Landa; Li-Ching Lee; Brooke Levenseller; Stacey Meyerer; Mohammad H Rahbar; Andria Ratchford; Ann Reynolds; Steven Rosenberg; Julie Rusyniak; Stuart K Shapira; Karen Smith; Margaret Souders; Patrick Aaron Thompson; Lisa Young; Marshalyn Yeargin-Allsopp Journal: J Autism Dev Disord Date: 2012-10
Authors: C Stoltenberg; S Schjølberg; M Bresnahan; M Hornig; D Hirtz; C Dahl; K K Lie; T Reichborn-Kjennerud; P Schreuder; E Alsaker; A-S Øyen; P Magnus; P Surén; E Susser; W I Lipkin Journal: Mol Psychiatry Date: 2010-07 Impact factor: 15.992
Authors: Susanne Buchmayer; Stefan Johansson; Anna Johansson; Christina M Hultman; Pär Sparén; Sven Cnattingius Journal: Pediatrics Date: 2009-10-19 Impact factor: 7.124
Authors: Roy M Nilsen; Stein Emil Vollset; Håkon K Gjessing; Rolv Skjaerven; Kari K Melve; Patricia Schreuder; Elin R Alsaker; Kjell Haug; Anne Kjersti Daltveit; Per Magnus Journal: Paediatr Perinat Epidemiol Date: 2009-11 Impact factor: 3.980
Authors: Elizabeth E Hatch; Kristen A Hahn; Lauren A Wise; Ellen M Mikkelsen; Ramya Kumar; Matthew P Fox; Daniel R Brooks; Anders H Riis; Henrik Toft Sorensen; Kenneth J Rothman Journal: Epidemiology Date: 2016-01 Impact factor: 4.822
Authors: Hunna J Watson; Ann Von Holle; Cecilie Knoph; Robert M Hamer; Leila Torgersen; Ted Reichborn-Kjennerud; Camilla Stoltenberg; Per Magnus; Cynthia M Bulik Journal: Int J Eat Disord Date: 2014-10-27 Impact factor: 4.861
Authors: Katharine K Brieger; Kelly M Bakulski; Celeste L Pearce; Ana Baylin; John F Dou; Jason I Feinberg; Lisa A Croen; Irva Hertz-Picciotto; Craig J Newschaffer; M Daniele Fallin; Rebecca J Schmidt Journal: J Autism Dev Disord Date: 2021-06-10